Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICDs, LVADs Will Drive Up Medicare Costs, Despite Improving Health – RAND

This article was originally published in The Gray Sheet

Executive Summary

Cardiac devices such as ICDs and LVADs pose a greater spending risk to Medicare than changing demographics and health trends, according to a study conducted by the RAND Corporation and published Sept. 26 on the website of the journal Health Affairs

You may also be interested in...



National Forum Proposed To Aid Hospitals In New Tech Adoption Decisions

A national forum should be developed to track and assess the cost-effectiveness of new technologies and aid hospitals in their adoption decisions, according to Molly Coye, CEO of the Health Technology Center

National Forum Proposed To Aid Hospitals In New Tech Adoption Decisions

A national forum should be developed to track and assess the cost-effectiveness of new technologies and aid hospitals in their adoption decisions, according to Molly Coye, CEO of the Health Technology Center

Health Plans Should Offer Choices For Technology Coverage – Wharton Prof

The U.S. Government should encourage the development of health insurance plans that provide consumers a choice of how new technology coverage decisions are made, according to a Wharton School researcher

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel